ATLANTA, Sept. 25, 2023 /PRNewswire/ -- Senores Pharmaceuticals, Inc. announced the launch of Nicardipine Hydrochloride Capsules USP, 20 mg and 30 mg, a bioequivalent and therapeutically equivalent to Cardene Capsules, 20 mg and 30 mg, of Chiesi USA, Inc. in the U.S. market. The product will be marketed by Burel Pharmaceuticals, LLC.
Senores' Generic Nicardipine Hydrochloride Receives Approval in the U.S.
Hyderabad, May 24 Dr. Reddy’s Laboratories Ltd and Senores Pharmaceuticals, Inc. have launched Ketorolac Tromethamine Tablets, a therapeutic generic equivalent of the reference listed drug Toradol Tablets, in the U.S. market with approval of the US Food and Drug Administration (USFDA).